News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Asian equities slipped as investors took profits in technology and chip stocks, with Nikkei and KOSPI among the worst performers.
  • Semiconductor and AI-related names drove steep losses in Japan and South Korea.
  • Speculation about an upcoming Bank of Japan rate discussion increased selling pressure.
  • Global geopolitical uncertainty added to risk-off sentiment among Asian investors.
  • OneSpaWorld promoted as a tactical long ahead of summer onboard spending, with a trade target at $27.50.
  • Chevron pitched as a tactical long as Middle East tensions lift oil risk-premia and support higher crude prices.

Latest Articles

Supreme Court Affirms SEC’s Right to Seek Disgorgement of Ill-Gotten Gains

Supreme Court Affirms SEC’s Right to Seek Disgorgement of Ill-Gotten Gains

The U.S. Supreme Court on Thursday unanimously backed the Securities and Exchange Commission’s ability to recover illegal profits through disgorgement, sustaining a lower-court ruling in a case brought by defendant Ongkaruck Sripetch. The decision leaves intact long-standing judicial and statutory foundations for disgorgement and resolves a central…

Supreme Court Unanimously Upholds SEC’s Broad Use of Disgorgement

Supreme Court Unanimously Upholds SEC’s Broad Use of Disgorgement

The U.S. Supreme Court on June 4 issued a unanimous decision siding with the Securities and Exchange Commission in a dispute over the scope of its disgorgement authority. The ruling affirms lower-court findings that the SEC may seek repayment of illegal profits even where the agency does not prove victims suffered monetary loss, and it follows liti…

IAEA Presses Iran to Disclose Status of Enriched Uranium After June Strikes

IAEA Presses Iran to Disclose Status of Enriched Uranium After June Strikes

The International Atomic Energy Agency has told member states that Iran must promptly provide information on its enriched uranium following military strikes on its nuclear sites in June 2025. A confidential IAEA report says the agency has not received required information, has been denied access to most facilities except Bushehr, and cannot verify …

Five Below Shares Drop Sharply as Guidance Assumptions Spur Investor Concern

Five Below Shares Drop Sharply as Guidance Assumptions Spur Investor Concern

Five Below reported stronger-than-expected fiscal Q1 2026 results, yet its stock plunged 12.1% in morning trading after an after-hours selloff extended into the regular session. The company topped consensus on both earnings and revenue, driven by substantial comparable-store sales and higher transaction volume. The market reaction centered on the c…

Pinterest Shares Jump After $4 Billion AWS Cloud Commitment Through 2031

Pinterest Shares Jump After $4 Billion AWS Cloud Commitment Through 2031

Pinterest shares rose sharply after the company disclosed a $4 billion agreement naming Amazon Web Services its Preferred Cloud Services Provider through 2031. The pact is intended to accelerate Pinterest’s AI roadmap, improve search and shopping responsiveness, and update the platform’s infrastructure that supports visual discovery for over 600 mi…

Nexalin Technology Announces Issuance of U.S. Patent Covering Dynamic Frequency Stimulation for Anxiety, Depression and Insomnia

Nexalin Technology Announces Issuance of U.S. Patent Covering Dynamic Frequency Stimulation for Anxiety, Depression and Insomnia

Nexalin Technology announced the issuance of U.S. Patent No. 12,629,519 for its transcranial alternating current dynamic frequency stimulation method targeting anxiety, depression, and insomnia. This patent strengthens the company's intellectual property portfolio, supporting its proprietary DIFS™ technology and virtual NeuroCare™ model for non-inv…

Micron Shares Plummet After Broadcom Shock Sends Semiconductor Stocks Lower

Micron Shares Plummet After Broadcom Shock Sends Semiconductor Stocks Lower

Micron Technology shares dropped sharply in morning trading after a broad selloff in the semiconductor sector was sparked by Broadcom’s post-earnings reaction. Despite strong revenue results at Broadcom, management’s decision not to lift its full-year AI semiconductor revenue target prompted a steep decline in that stock and a sector-wide de-riskin…

Why Alphabet’s $85B Share Sale Rewrites The Liquidity Playbook

Why Alphabet’s $85B Share Sale Rewrites The Liquidity Playbook

Alphabet's $85 billion stock sale is larger than most corporate liquidity events and will materially increase tradable supply, alter ETF/prime broker flows and shift buyback math. That creates a short-term dislocation and a mid-to-long-term opportunity to buy quality cash flow at a modest multiple if management deploys proceeds rationally. Trade pl…

Rumble Stock Pops After $270M GPU Cloud Deal as Cloud Pivot Gains Traction

Rumble Stock Pops After $270M GPU Cloud Deal as Cloud Pivot Gains Traction

Rumble's shares jumped sharply after the company announced a $270 million, multi-year contract for dedicated GPU cloud capacity. The agreement, signed June 3, 2026, involves NVIDIA Blackwell B300 systems and may increase in value or duration tied to market performance. The deal strengthens Rumble's push into cloud services and AI compute as the fir…

MAIA Biotechnology Reports Strong Enrollment and Dosing Momentum in Pivotal Phase 3 Non-Small Cell Lung Cancer Trial

MAIA Biotechnology Reports Strong Enrollment and Dosing Momentum in Pivotal Phase 3 Non-Small Cell Lung Cancer Trial

MAIA Biotechnology reports strong patient enrollment and dosing progress in its pivotal Phase 3 THIO-104 clinical trial evaluating ateganosine, a first-in-class telomere-targeting therapy for third-line treatment of advanced non-small cell lung cancer (NSCLC). The therapy shows a high potential based on favorable Phase 2 results and holds significa…

Publicis Upgrade: Buy the Dip — AI Angst Has Been Priced In

Publicis Upgrade: Buy the Dip — AI Angst Has Been Priced In

Publicis (PUBGY) looks like a classic opportunity to buy on fear: the business is cash-generative, pays a healthy yield, and is doubling down on AI through a strategic Microsoft relationship. Valuation is reasonable (P/E ~13.3, market cap ~$26.1B) and technical momentum is bullish. I upgrade to a buy and lay out an actionable trade with entry, stop…